Your browser doesn't support javascript.
loading
Higher rate of progression in HIV- than in HIV+ patients after rituximab for HHV8+ multicentric Castleman disease.
Rasmussen, Camille; Gérard, Laurence; Fadlallah, Jehane; Corvilain, Emilie; Galicier, Lionel; Meignin, Véronique; Oksenhendler, Eric; Boutboul, David.
Afiliação
  • Rasmussen C; Department of Clinical Immunology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Gérard L; Department of Clinical Immunology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Fadlallah J; Department of Clinical Immunology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Corvilain E; Department of Clinical Immunology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Galicier L; Department of Clinical Immunology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Meignin V; National Reference Center for Castleman Disease, Paris, France.
  • Oksenhendler E; Department of Pathology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Boutboul D; Department of Clinical Immunology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.
Blood Adv ; 7(18): 5663-5669, 2023 09 26.
Article em En | MEDLINE | ID: mdl-37288720
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoma de Kaposi / Infecções por HIV / Hiperplasia do Linfonodo Gigante / Herpesvirus Humano 8 Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoma de Kaposi / Infecções por HIV / Hiperplasia do Linfonodo Gigante / Herpesvirus Humano 8 Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França